Skopos Labs, Inc. Veracyte, Inc. Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 89 shares of VCYT stock, worth $2,401. This represents 0.0% of its overall portfolio holdings.
Number of Shares
89
Previous 5
1680.0%
Holding current value
$2,401
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VCYT
# of Institutions
306Shares Held
79.1MCall Options Held
15.5KPut Options Held
16.7K-
Vanguard Group Inc Valley Forge, PA8.26MShares$223 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$210 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.24MShares$141 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.94MShares$106 Million1.26% of portfolio
-
Wellington Management Group LLP Boston, MA3.85MShares$104 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $1.93B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...